Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.43
-0.41 (-3.46%)
May 28, 2026, 10:59 AM HKT
Market Cap5.41B
Revenue (ttm)146.34M
Net Income-379.87M
EPS-0.88
Shares Out 456.82M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,455,200
Open11.98
Previous Close11.84
Day's Range11.40 - 12.74
52-Week Range11.15 - 74.00
Betan/a
AnalystsStrong Buy
Price Target31.63 (+176.73%)
Earnings DateAug 28, 2026

About HKG:2591

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drugs. The company’s products are used for the treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 193
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2591
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements